secwatch.observer — SEC 8-K summary
======================================

Issuer:     MetaVia Inc. (MTVA)
CIK:        0001638287
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001558370-24-002312
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroBo appoints Marshall Woodworth as permanent CFO effective March 1, 2024
----------------------------------------------------------------------------

- Marshall Woodworth, age 66, appointed CFO, Principal Financial Officer and Principal Accounting Officer.
- Previously served as Acting CFO since Oct 27, 2023; engagement with WhiteCap Search terminated.
- Employment agreement: 2-year initial term, $380,000 base salary, 40% target bonus, 33,496 RSUs.
- Background: CFO at Nevakar, Braeburn, Aerocrine, and Furiex Pharmaceuticals (Nasdaq: FURX).
- Company highlights upcoming Phase 2a data for DA-1241 (MASH) and Phase 1 start for DA-1726 (obesity).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638287/000155837024002312/0001558370-24-002312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638287/000155837024002312/nrbo-20240304x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-002312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer